- Home
- PMX vs ANIK Comparison
PMX vs ANIK Comparison
Compare PMX & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMX
- ANIK
- Stock Information
- Founded
- PMX 2002
- ANIK 1983
- Country
- PMX United States
- ANIK United States
- Employees
- PMX N/A
- ANIK N/A
- Industry
- PMX Trusts Except Educational Religious and Charitable
- ANIK Medical/Dental Instruments
- Sector
- PMX Finance
- ANIK Health Care
- Exchange
- PMX Nasdaq
- ANIK Nasdaq
- Market Cap
- PMX 240.0M
- ANIK 243.4M
- IPO Year
- PMX N/A
- ANIK 1993
- Fundamental
- Price
- PMX $7.22
- ANIK $15.03
- Analyst Decision
- PMX
- ANIK Buy
- Analyst Count
- PMX 0
- ANIK 2
- Target Price
- PMX N/A
- ANIK $22.00
- AVG Volume (30 Days)
- PMX 101.5K
- ANIK 88.6K
- Earning Date
- PMX 01-01-0001
- ANIK 03-12-2025
- Dividend Yield
- PMX 5.28%
- ANIK N/A
- EPS Growth
- PMX N/A
- ANIK N/A
- EPS
- PMX N/A
- ANIK N/A
- Revenue
- PMX N/A
- ANIK $119,907,000.00
- Revenue This Year
- PMX N/A
- ANIK N/A
- Revenue Next Year
- PMX N/A
- ANIK $8.50
- P/E Ratio
- PMX N/A
- ANIK N/A
- Revenue Growth
- PMX N/A
- ANIK N/A
- 52 Week Low
- PMX $6.09
- ANIK $14.79
- 52 Week High
- PMX $8.47
- ANIK $29.12
- Technical
- Relative Strength Index (RSI)
- PMX 45.61
- ANIK 34.68
- Support Level
- PMX $7.07
- ANIK $14.79
- Resistance Level
- PMX $7.27
- ANIK $15.79
- Average True Range (ATR)
- PMX 0.07
- ANIK 0.70
- MACD
- PMX -0.00
- ANIK -0.06
- Stochastic Oscillator
- PMX 72.50
- ANIK 10.39
About PMX PIMCO Municipal Income Fund III of Beneficial Interest
PIMCO Municipal Income Fund III is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal income tax. The fund portfolio of investments consists of investments in different sectors such as transportation, healthcare, and others.
About ANIK Anika Therapeutics Inc.
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States.